New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum

E-ISSN： 1875-533x|17|10|1002-1009

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.10, 2010-04, pp. : 1002-1009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management

By Rabinovici Gil D. Miller Bruce L.

CNS Drugs, Vol. 24, Iss. 5, 2010-05 ,pp. : 375-398

Adis International

Access to resources Recommend Favorite

Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management

By Seltman Rachel E. Matthews Brandy R.

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 841-870

Adis International

Access to resources Recommend Favorite

Disease-Modifying Therapies in Frontotemporal Lobar Degeneration

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 1008-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Contributors to Frontotemporal Lobar Degeneration: Beyond Monogenic Disease

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-10 ,pp. : 988-1001

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into the biological therapy of Crohn’s disease

By Hassan Cesare Zullo Angelo Campo Salvatore MA Morini Sergio

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 409-419

Informa Healthcare

Access to resources Recommend Favorite